Koninklijke Philips | PHG - Selling And Administration Expenses


Koninklijke Philips reported EUR1.38B in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Baxter International USD 761M 53M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Boston Scientific USD 1.83B 93M Dec/2025
Danaher USD 2.03B 35M Dec/2025
Demant DKK 6.09B 135M Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
Edwards Lifesciences USD 602.9M 88.3M Dec/2025
Fresenius EUR 676M 64M Sep/2025
General Electric Aerospace USD 1.58B 385M Dec/2025
Getinge SEK 2.65B 452M Dec/2024
Globus Medical USD 313.6M 9.98M Sep/2025
GN Store Nord DKK 1.45B 41M Dec/2025
Hitachi JPY 491.37B 24.02B Dec/2025
Hologic USD 2.5B 2.24B Dec/2025
Idexx Laboratories USD 275.68M 10.58M Dec/2025
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 169.05M 10.84M Sep/2025
Intuitive Surgical USD 687.1M 113.8M Dec/2025
J&J USD 6.75B 831M Dec/2025
Koninklijke Philips EUR 1.38B 137.87M Sep/2025
Masimo USD 116.4M 20.5M Sep/2025
Medtronic 2.97B 159M Sep/2025
Philips EUR 1.31B 127M Dec/2025
ResMed USD 278.4M 19.2M Dec/2025
Smith & Nephew USD 1.42B 65M Dec/2025
Steris USD 352.3M 2.6M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Teleflex USD 281.76M 66.68M Sep/2025
Terumo JPY 105.26B 7.38B Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025